Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

However, in evaluating treatment models of such guidelines one can see how recent the use of physical rehabilitation is as adjuvant for NP treatment. In summary, documents directed to neuropathic pain ...

NIBS has been employed effectively for exploring mechanisms underlying normal and pathological pain processing, and also for the treatment of different chronic neuropathic and non-neuropathic pain ...

Changes in the brain with cortical reorganisation to gut stimulation and increased activity in specific electroencephalographic features characteristic for neuropathic pain are also seen in patients ...

Conclusion: Pregabalin may be beneficial for the treatment of neuropathic pain or partial-onset seizures in patients who do not respond to conventional treatments or cannot tolerate their adverse ...

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, gabapentinoid use increased eightfold between 2012 and 2018, with one in seven Australians aged 80 and older ...

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, gabapentinoid use increased eightfold between 2012 and 2018, with one in seven Australians aged 80 and older ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

This Research Topic seeks contributions that examine non-coding RNAs' roles in neuropathic pain regulation and treatment. We invite studies on how altered non-coding RNA expression affects pain ...

Gary S. Jacob, CEO of OKYO Pharma. “This is a key step forward in our mission to provide relief for patients suffering from neuropathic corneal pain, a chronic condition for which no FDA-approved ...